Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
Greg.Corboy1 (talk | contribs)
editor
107 edits
Tags: Visual edit Mobile edit Mobile web edit
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(61 intermediate revisions by 5 users not shown)
Line 1: Line 1:
Welcome! 


*For assignments, please see the "Author" column below.  If no name is present, volunteer to create content!
*We will be creating content for all entities with genetic findings in the current WHO Classification of Tumours books.  If there is an entity not yet listed below that you would like to author, we would be happy to create a page for you now.
*To volunteer, please '''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your page of interest.
__TOC__
==WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content==
{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
Line 23: Line 17:
|
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|Date page was created
|
|
|
|-
|-
Line 33: Line 27:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 43: Line 37:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 67: Line 61:
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|
|
|complete
|complete/pending faculty review
|
|
|FQR
|FQR
|
|
|8/1/21 FQR deleted "'''This page is under construction'''
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|Chelsea D. Kramish (trainee), Daynna J.Wolff
|(trainee), Daynna J.Wolff
|
|
|
|
|complete/pending faculty review
|pending faculty review
|
|
|FQR
|FQR
Line 88: Line 82:
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|Thomas Lee
|
|8/17/2020
|
|9/7/2020
|complete
|complete
|
|
Line 96: Line 90:
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''||Shashi Shetty, Ph.D.
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|
Line 105: Line 99:
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung + Shuo-Shawn Liu (trainee)
|Thuy Phung/Shuo-Shawn Liu
|
|
|
|
|complete
|complete/pending adding content online as of 2/4/21
|
|
|FQR
|FQR
|
|
|8/1/21 FQR deleted "'''This page is under construction'''
|
|-
|-
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
Line 125: Line 119:
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery (trainee)
|Thuy Phung +Jordan Lowery
|
|
|
|
Line 181: Line 175:
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|
|
Line 192: Line 186:
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Disease
|Lauren R. Crowson-Hindman (trainee) + Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|
|
Line 231: Line 225:
|
|
|9/1/20
|9/1/20
|PENDING reference formatting
|PENDING
|
|
|FQR
|FQR
Line 243: Line 237:
|
|
|FQR
|FQR
|Date page was created
|
|
|
|-
|-
Line 293: Line 287:
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 303: Line 297:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 330: Line 324:
|
|
|9/1/20
|9/1/20
|Complete
|PENDING
|
|
|FQR
|FQR
Line 474: Line 468:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
Corboy (Monash Health)
|
|
|
|
Line 483: Line 476:
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 491: Line 484:
|Add WHO reference
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Corboy (Monash Health)
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|
|
Line 709: Line 702:
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Disease
|Kay Weng Choy + Greg Corboy (Monash Health)
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
Line 764: Line 757:
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain (trainee) + Yassmine Akkari
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|
Line 836: Line 829:
|
|
|
|
|Complete
|PENDING
| ||YA
| ||YA
|
|
Line 929: Line 922:
| ||YA
| ||YA
|
|
|2021 template added
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
Line 937: Line 930:
| ||YA
| ||YA
|
|
|2021 template added
|
|-
|-
| || ||
| || ||
Line 955: Line 948:
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Jamie Nagy
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|10/25/21
|
|
|
|
|PENDING
|
|
|SP
|SP
Line 964: Line 957:
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Jamie Nagy
|       Monoclonal B-cell  Lymphocytosis||Disease||
|10/25/21
|
|
|PENDING
|
|
|SP
|
|
|SP
|
|
|
|
Line 1,061: Line 1,054:
|
|
|-
|-
|    Mu Heavy Chain  Disease||Disease||Manisha Sutariya
|    Mu Heavy Chain  Disease||Disease||
|
|
|
|
Line 1,130: Line 1,123:
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||Chen Yang, MD, PhD
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|           Primary  Amyloidosis||Disease||Heather E. Williams, PhD
|           Primary  Amyloidosis||Disease||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||Chen Yang, MD, PhD
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||Sohini Anand
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|8/31/2021
|
|9/15/2021
|
|PENDING
|
| ||SP
| ||SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease||Sohini Anand, MBBS, and Tharanga Niroshini Senaratne, PhD
|         POEMS Syndrome||Disease||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease||Sohini Anand, MBBS
|         TEMPI Syndrome||Disease||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee (trainee)/Fabiola Quintero-Rivera
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|3/9/21
|
|
Line 1,274: Line 1,267:
|
|
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari, MD
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|?PENDING
|
|
|SP
|SP
Line 1,307: Line 1,300:
|Greg Corboy (GC)
|Greg Corboy (GC)
|
|
|Requested to update 14022022
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
Line 1,317: Line 1,310:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|26/10/2021
|
|26/1/2022
|
|PENDING
|
| ||GC
| ||GC
|
|
|2021 template added
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
Line 1,381: Line 1,374:
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease||Kate Berry, Greg Corboy
|Intravascular Large B-cell Lymphoma||Disease||
|25/01/2022
|
|25/4/2022
|
|PENDING
|
| ||GC
| ||GC
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease||Nakasaki, Manando(trainee)+ Fabiola Quintero-Rivera
|ALK-Positive Large B-cell Lymphoma||Disease||
|6/1/21
|
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|Contacted Jan 2022 no reply, followed up with Fabiola Feb 2022
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
Line 1,421: Line 1,414:
|
|
|-
|-
|   Multicentric Castleman  Disease||Disease||Sudha Arumugam
|   Multicentric Castleman  Disease||Disease||
|10/26/2021
|
|1/26/2022
|
|Complete
|24/01/2022||GC
|24/01/2022
|2021 template added
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sudha Arumugam
|10/26/2021
|1/26/2022
|PENDING
| ||GC
|
|
|2021 template added
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||Sudha Arumugam
|10/26/2021
|1/26/2022
|PENDING
| ||GC
| ||GC
|
|
|2021 template added
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|06/28/2021
|Complete
|28/06/2021||GC
|28/06/2021
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease||Lauren Shealy (trainee), Daynna Wolff
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|10/13/21
|01/13/2022
|Complete
|27/01/2022
|GC
|27/01/2021
|2021 template added
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
Line 1,470: Line 1,430:
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||Kate Berry, Greg Corboy
|   HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||
|30/05/21
|
|30/08/21
|Complete
|24/02/2022||GC
|24/02/2022
|
|
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Aiko Otsubo, Holli Drendel
|7/30/21
|10/30/21
|Complete
|15/11/2021
|GC
|16/11/2021
|
|
|-
| ||GC
|B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|-
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|
|PENDING
| ||GC
| ||GC
|
|
|
|
|-
|-
| || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
| ||GC
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|PENDING
|
| ||SP
| ||GC
|
|
|
|
|-
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||GC
| ||SP
|
|
|
|
|-
|-
|Aggressive NK-cell Leukemia||Disease||Shanelle De Lancy, MD, Shashirekha Shetty, PhD
| || ||
|
|
|
|
|?PENDING
|
| ||SP
| ||
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|Complete
|PENDING
|11/21/2021||SP
| ||SP
|
|
|
|
|-
|-
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Hydroa Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Severe Mosquito Bite  Allergy||Disease||
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
Line 1,583: Line 1,534:
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease||Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
|?PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
Line 1,644: Line 1,599:
|
|
|-
|-
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
Line 1,653: Line 1,608:
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|PENDING
| ||SP
|
|SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||Peining Li, PhD
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|PENDING
|Complete
| ||SP
|1/21/2021
|SP
|
|
|
|
|-
|-
|    Lymphomatoid  Papulosis||Disease||Peining Li, PhD
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||Theresa Spivey, MD, Shashirekha Shetty, PhD
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
Line 1,701: Line 1,660:
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||Peining Li, PhD
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
Line 1,709: Line 1,668:
|
|
|-
|-
|     Primary Cutaneous Gamma Delta T-cell Lymphoma||Disease||Peining Li, PhD
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||Peining Li, PhD
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||Peining Li, PhD
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||Peining Li, PhD
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
Line 1,749: Line 1,708:
|
|
|-
|-
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
Line 1,757: Line 1,716:
|
|
|-
|-
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Follicular T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|PENDING
| ||SP
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
Line 1,801: Line 1,757:
|
|
|-
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
Line 1,810: Line 1,766:
|
|
|-
|-
| || ||
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||
| ||SP
|
|
|
|
|-
|-
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||Greg Corboy (GC)
|SP
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
| ||GC
|SP
|
|
|
|
|-
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||Xiaolin (Lynn) Hu
| || ||
|
|
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
| ||
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|PENDING
| ||GC
|
|2021 template added
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|
|
| ||Greg Corboy (GC)
|
|
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,882: Line 1,825:
|
|
|-
|-
|Lymphomas Associated with HIV Infection||Disease||Patricia V. Hernandez, M.D. (trainee)+Holli Drendel
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|11/2/21
|
|
|
|
|PENDING
| ||GC
| ||GC
|
|
|2021 template added
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,898: Line 1,841:
|
|
|-
|-
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|    Lymphocyte-Rich Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,906: Line 1,849:
|
|
|-
|-
|    Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
|    Mixed Cellularity Classic Hodgkin Lymphoma||Disease||
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
|GC
| ||GC
|
|
|
|
|-
|-
|'''''    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|    Lymphocyte-Depleted Classic Hodgkin Lymphoma||Disease||
|
|
|
|
Line 1,925: Line 1,865:
|
|
|-
|-
|          Monomorphic  B-cell PTLD||Disease||
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,933: Line 1,873:
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
|
Line 1,941: Line 1,881:
|
|
|-
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
Line 1,949: Line 1,889:
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
|
Line 1,957: Line 1,897:
|
|
|-
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|
|
|PENDING
|
|
| ||GC
|GC
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease||Marie-France Gagnon, MD, Mayo Clinic (LGG fellow trainee), Xinjie Xu, PhD FACMG, Mayo Clinic
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
|
|
|Complete
| ||GC
|10/01/2021
|GC
|10/01/2021
|Xinjie Xu
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
| ||GC
|
|
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|PENDING
| ||GC
| ||GC
|
|
|2021 template added
|-
|   Langerhans Cell  Sarcoma||Disease||Malaika Perchard, Greg Corboy
|02/01/2022
|05/01/2022
|PENDING
| ||GC
|
|
|2021 template added
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
|
Line 2,006: Line 1,932:
|
|
|-
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
|
Line 2,014: Line 1,940:
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
|
Line 2,022: Line 1,948:
|
|
|-
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
Line 2,030: Line 1,956:
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|Histiocytic Sarcoma||Disease||
|
|
|
|
Line 2,038: Line 1,964:
|
|
|-
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
|
Line 2,046: Line 1,972:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||Prashant Deshpande
|   Langerhans Cell  Histiocytosis||Disease||
|02/02/2022
|
|05/02/2022
|
|PENDING
|
| ||GC
| ||GC
|
|
|2021 template added
|
|-
|-
| || ||
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
|-
|-
| || ||
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 2,213: Line 2,139:
|
|
|
|
|}<br />
==WHO Classification of Tumours of the Central Nervous System Content==
{| class="wikitable"
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
| || ||
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|
|
|PENDING
|
|
| ||
|
|
|
|
|2021 template added
|-
|-
|Paediatric-type diffuse high-grade gliomas
| || ||
|Overview
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|2021 template added
|-
|-
|Diffuse midline glioma, H3 K27-altered
| || ||
|Disease
|Laveniya Satgunaseelan
|
|
|
|
|
|
| ||
|
|
|
|
|
|2021 template added
|-
|-
|Diffuse hemispheric glioma, H3 G34-mutant
| || ||
|Disease
|
|
|
|
|
|
| ||
|
|
|
|-
| || ||
|
|
|
|
|
|
|2021 template added
| ||
|-
|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
|Disease
|
|
|
|
|-
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|2021 template added
|-
|-
|Infant-type hemispheric glioma
| || ||
|Disease
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|2021 template added
|-
|-
|}<br />
| || ||
 
==WHO Classification of Soft Tissue and Bone Tumours Content==
{| class="wikitable"
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|'''''Pending'''''||'''''Disease'''''||Pending
|Pending
|
|
|PENDING
|
|
|
|
| ||
|
|
|
|
|-
|}
|}<br />
 
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
{| class="wikitable sortable"
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Gene'''
!'''Author'''
!'''Author'''
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"